ArticleAtovaquone and proguanil for Plasmodium falciparum malaria
References (30)
- et al.
The epidemiology of drug-resistant malaria
Trans R Soc Trop Med Hyg
(1990) - et al.
Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria
Lancet
(1986) - et al.
Drug therapy for Plasmodium falciparum malaria resistant to pyrimethamine-sulfadoxine (Fansidar). A study of alternate regimens in Eastern Thailand, 1980
Lancet
(1981) - et al.
Fast emergence of Plasmodium falciparum resistance to halofantrine
Lancet
(1993) - et al.
Cardiac effects of antimalarial treatment with halofantrine
Lancet
(1993) - et al.
Inhibition of pyrimidine biosynthesis de novo in Plasmodium falciparum by 2-(4-t-lutylcyclohexyl)-3-hydroxy-1,4-naphthoquinone in vitro
Mol Biochem Parasitol
(1985) - et al.
Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro
Exp Parasitol
(1995) - et al.
Multiresistant falciparum malaria cured using atovaquone and proguanil
Trans R Soc Trop Med Hyg
(1994) World Malaria situation in 1992
Weekly Epidemiol Rec
(1994)Antimalarial drug resistance: the pace quickens
J Antimicrob Chemother
(1992)
Treatment of malaria—1990
Drugs
(1990)
Amodiaquine induced agranulocytosis and liver damage
BMJ
(1986)
Quinine plus clindamycin improves chemotherapy of severe malaria in children
Antimicrob Agents Chemother
(1995)
High efficacy of short term quinine-antibiotic combinations for treating adult malaria patients in an area in which malaria is hyperendemic
Antimicrob Agents Chemother
(1995)
Cited by (168)
Current scenario of artemisinin and its analogues for antimalarial activity
2019, European Journal of Medicinal ChemistryAntiparasitic Agents
2018, Principles and Practice of Pediatric Infectious DiseasesClomipramine and benznidazole association for the treatment of acute experimental Trypanosoma cruzi infection
2013, Parasitology InternationalCitation Excerpt :The combination of drugs can be a valuable way to improve the efficacy of treatment in a variety of diseases. This has been demonstrated by several authors in the treatment of tuberculosis [14], and in Chagas disease with the combination of benznidazole and ketoconazole [15], clomipramine and allopurinol [9], among others. The present work evaluated the effect of the association of clomipramine and benznidazole (at different doses) for the treatment of experimental Chagas disease in the acute stage, in Swiss albino mice infected with T. cruzi Tulahuen strain (Tc VI) [16].
Atovaquone impairs growth of aspergillus and fusarium keratitis isolates by modulating mitochondrial function and zinc homeostasis
2018, Investigative Ophthalmology and Visual ScienceOXPHOS-targeting drugs in oncology: new perspectives
2023, Expert Opinion on Therapeutic Targets
Copyright © 1996 Published by Elsevier Ltd.